Value of Magnetic Resonance Spectroscopy Imaging and Dynamic Contrast-Enhanced Imaging for Detecting Prostate Cancer Foci in Men With Prior Negative Biopsy
暂无分享,去创建一个
Roberto Passariello | Valeria Panebianco | Alessandro Sciarra | Vincenzo Gentile | R. Passariello | V. Panebianco | A. Sciarra | S. Bernardo | S. Cattarino | V. Gentile | Mauro Ciccariello | Stefano Salciccia | Susanna Cattarino | Danilo Lisi | Alessandro Gentilucci | Andrea Alfarone | Silvia Bernardo | A. Alfarone | S. Salciccia | A. Gentilucci | M. Ciccariello | D. Lisi
[1] J. Kurhanewicz,et al. Prostate cancer: sextant localization with MR imaging, MR spectroscopy, and 11C-choline PET/CT. , 2007, Radiology.
[2] S. Zangos,et al. Three-dimensional 1H-magnetic resonance spectroscopy of the prostate in clinical practice: technique and results in patients with elevated prostate-specific antigen and negative or no previous prostate biopsies , 2005, European Radiology.
[3] D. Regge,et al. Value of endorectal MRI and MRS in patients with elevated prostate-specific antigen levels and previous negative biopsies to localize peripheral zone tumours. , 2008, Clinical radiology.
[4] Amit Patel,et al. Prostate cancer detection with office based saturation biopsy in a repeat biopsy population. , 2004, The Journal of urology.
[5] Heinz-Peter Schlemmer,et al. MRI-guided biopsy of the prostate increases diagnostic performance in men with elevated or increasing PSA levels after previous negative TRUS biopsies. , 2006, European urology.
[6] Rajeev Kumar,et al. Potential of magnetic resonance spectroscopic imaging in predicting absence of prostate cancer in men with serum prostate-specific antigen between 4 and 10 ng/ml: a follow-up study. , 2008, Urology.
[7] P. Carroll,et al. Prostate cancer: metabolic response to cryosurgery as detected with 3D H-1 MR spectroscopic imaging. , 1996, Radiology.
[8] J. Vilanova,et al. The value of endorectal MR imaging to predict positive biopsies in clinically intermediate-risk prostate cancer patients , 2001, European Radiology.
[9] Rodolfo Montironi,et al. Extended and saturation prostatic biopsy in the diagnosis and characterisation of prostate cancer: a critical analysis of the literature. , 2007, European urology.
[10] M. Zerbib,et al. Negative prostatic biopsies in patients with a high risk of prostate cancer. Is the combination of endorectal MRI and magnetic resonance spectroscopy imaging (MRSI) a useful tool? A preliminary study. , 2005, European urology.
[11] J Kurhanewicz,et al. Sextant localization of prostate cancer: comparison of sextant biopsy, magnetic resonance imaging and magnetic resonance spectroscopic imaging with step section histology. , 2000, The Journal of urology.
[12] Amita Shukla-Dave,et al. Functional magnetic resonance imaging in prostate cancer. , 2009, European urology.
[13] A. Sciarra,et al. Biopsy-Derived Gleason Artifact and Prostate Volume: Experience Using Ten Samples in Larger Prostates , 2008, Urologia Internationalis.
[14] J. Hugosson,et al. The risk of finding focal cancer (less than 3 mm) remains high on re-biopsy of patients with persistently increased prostate specific antigen but the clinical significance is questionable. , 2004, The Journal of urology.
[15] W S Ng,et al. Endorectal magnetic resonance imaging and spectroscopy for the detection of tumor foci in men with prior negative transrectal ultrasound prostate biopsy. , 2004, The Journal of urology.
[16] F. Coakley,et al. MR imaging and MR spectroscopic imaging of prostate cancer. , 2004, Magnetic resonance imaging clinics of North America.
[17] J. Kurhanewicz,et al. 3D MR spectroscopic imaging in the evaluation of prostate cancer. , 2007, Clinical radiology.
[18] R. Passariello,et al. 2D and 3D T2-weighted MR sequences for the assessment of neurovascular bundle changes after nerve-sparing radical retropubic prostatectomy with erectile function correlation , 2008, European Radiology.
[19] Mark Emberton,et al. THE ROLE OF MAGNETIC RESONANCE IMAGING IN TARGETING PROSTATE CANCER IN PATIENTS WITH PREVIOUS NEGATIVE BIOPSIES AND ELEVATED PROSTATE‐SPECIFIC ANTIGEN LEVELS , 2009, BJU international.
[20] K. Badani,et al. Prospective evaluation of endorectal magnetic resonance imaging to detect tumor foci in men with prior negative prostastic biopsy: a pilot study. , 2000, The Journal of urology.
[21] G. Gualdi,et al. Prostate cancer: value of magnetic resonance spectroscopy 3D chemical shift imaging , 2006, Abdominal Imaging.
[22] H. Huisman,et al. Prostate cancer localization with dynamic contrast-enhanced MR imaging and proton MR spectroscopic imaging. , 2006, Radiology.
[23] H. Hricak,et al. MR imaging and MR spectroscopic imaging in the pre-treatment evaluation of prostate cancer. , 2005, The British journal of radiology.
[24] G. Haas,et al. Saturation biopsies for prostate cancer: current uses and future prospects , 2009, Nature Reviews Urology.
[25] Clare Allen,et al. How good is MRI at detecting and characterising cancer within the prostate? , 2006, European urology.
[26] M. Kattan,et al. Correlation of proton MR spectroscopic imaging with gleason score based on step-section pathologic analysis after radical prostatectomy. , 2005, Radiology.
[27] V. Panebianco,et al. Proton spectroscopic and dynamic contrast-enhanced magnetic resonance: a modern approach in prostate cancer imaging. , 2008, European urology.
[28] M. Blomley,et al. Imaging investigation of liver haemodynamics in patients at risk for hepatic metastatic disease. , 2005, The British journal of radiology.
[29] Roberto Passariello,et al. Role of dynamic contrast-enhanced magnetic resonance (MR) imaging and proton MR spectroscopic imaging in the detection of local recurrence after radical prostatectomy for prostate cancer. , 2008, European urology.